Efficacy and safety of sargramostimt in moderate to severe Crohn's disease: Results of NOVEL 4, a phase III multicenter study

被引：0
|
作者：
Feagan, Brian G.
Anderson, Frank
Radford-smith, Gnaharn L.
Solovyov, Oleg
Zurdel-dillinger, Sabine
机构：
来源：
GASTROENTEROLOGY | 2007年 / 132卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A103 / A103
页数：1
相关论文
共 50 条
  • [41] EFFICACY AND SAFETY OF ADALIMUMAB IN PATIENTS WITH MODERATE TO SEVERE CROHN'S DISEASE: A SINGLE CENTRE EXPERIENCE OF OUT OF LABEL USE
    Scribano, M. L.
    Kohn, A.
    Meddi, P.
    Giglio, L. A.
    Prantera, C.
    DIGESTIVE AND LIVER DISEASE, 2008, 40 : S184 - S185
  • [42] Efficacy and Safety of Adalimumab in Moderate Compared with Severe Crohn's Disease: Pooled Data from the CHARM and EXTEND Trials
    Colombel, Jean-Frederic
    Sandborn, William
    Castillo, Majin
    Zhou, Qian
    Thakkar, Roopal
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S434 - S435
  • [43] EFFICACY AND SAFETY OF ADALIMUMAB IN MODERATE COMPARED WITH SEVERE CROHN'S DISEASE: POOLED DATA FROM THE CHARM AND EXTEND TRIALS
    Colombel, J-F
    Sandborn, W. J.
    Castillo, M. M.
    Zhou, Q.
    Thakkar, R. B.
    GUT, 2012, 61 : A229 - A229
  • [44] Efficacy, Safety, Patient Experience, and Tolerability of Risankizumab Administered by On-Body Injector for Moderate to Severe Crohn’s Disease
    Edward V. Loftus
    Jenny Griffith
    Ezequiel Neimark
    Alexandra Song
    Kori Wallace
    Sujani Nannapaneni
    Ji Zhou
    Rachel Byrne
    Kristina Kligys
    Yinuo Pang
    Xiaomei Liao
    Jasmina Kalabic
    Marla Dubinsky
    Advances in Therapy, 2023, 40 : 2311 - 2325
  • [45] A novel nonabsorbable antibiotic (rifaximin) in the treatment of moderate to severe Crohn's disease
    Bosworth, BP
    Scherl, EJ
    GASTROENTEROLOGY, 2005, 128 (04) : A576 - A576
  • [46] Safety and efficacy of capsule endoscopy for patients with newly diagnosed Crohn's disease: A multicenter retrospective study
    Kawano, Seiji
    Oka, Shiro
    Shiotani, Akiko
    Hashimoto, Shinichi
    Takahashi, Sakuma
    Handa, Osamu
    Takami, Taro
    Inaba, Tomoki
    Okada, Hiroyuki
    Tanaka, Shinji
    MEDICINE, 2022, 101 (50)
  • [47] Effectiveness, safety and durability of vedolizumab in active moderate-severe Crohn's Disease
    Morales Bermudez, A. I.
    Bracho Gonzalez, M.
    Gomez Rodriguez, P.
    Olmedo Martin, R.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I489 - I490
  • [48] Adalimumab in Japanese patients with moderate to severe chronic plaque psoriasis: Efficacy and safety results from a Phase II/III randomized controlled study
    Asahina, Akihiko
    Nakagawa, Hidemi
    Etoh, Takafumi
    Ohtsuki, Mamitaro
    JOURNAL OF DERMATOLOGY, 2010, 37 (04): : 299 - 310
  • [49] Efficacy and safety of abrocitinib in patients with moderate-to-severe atopic dermatitis: results from the phase III, JADE MONO-1 study
    Simpson, E. L.
    Sinclair, R.
    Forman, S.
    Wollenberg, A.
    Asch, R.
    Cork, M.
    Bieber, T.
    Thyssen, J. P.
    Yosipovitch, G.
    Magnolo, N.
    Maari, C.
    Flohr, C.
    Feeney, C.
    Biswas, P.
    Tatulych, S.
    Valdez, H.
    Rojo, R.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 (04) : E105 - E106
  • [50] Efficacy and safety of abrocitinib in patients with moderate-to-severe atopic dermatitis: results from the phase III JADE MONO-2 study
    Silverberg, J.
    Simpson, E. L.
    Thyssen, J. P.
    Gooderham, M.
    Chan, G.
    Feeney, C.
    Biswas, P.
    Valdez, H.
    DiBonaventura, M.
    Nduaka, C.
    Rojo, R.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 (04) : E100 - E100
12345